$2.8 Billion is the total value of Tekla Capital Management LLC's 152 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | Gilead Sciences, Inc. | $226,948,000 | +26.7% | 2,801,131 | +10.7% | 8.11% | +22.3% |
| CELG | Sell | Celgene Corporation | $202,329,000 | +7.0% | 1,387,525 | -4.7% | 7.23% | +3.2% |
| BIIB | Sell | Biogen Inc. | $153,305,000 | +6.6% | 489,604 | -7.6% | 5.48% | +2.9% |
| AMGN | Sell | Amgen Inc. | $115,650,000 | -1.9% | 620,274 | -9.4% | 4.13% | -5.4% |
| VRTX | Sell | Vertex Pharmaceuticals Incorporated | $111,160,000 | +8.1% | 731,123 | -8.4% | 3.97% | +4.3% |
| ALXN | Alexion Pharmaceuticals, Inc. | $105,344,000 | +15.3% | 750,905 | 0.0% | 3.77% | +11.3% | |
| JNJ | Buy | Johnson & Johnson | $103,869,000 | +9.9% | 798,932 | +11.8% | 3.71% | +6.1% |
| MRK | Merck & Co., Inc. | $94,335,000 | -0.1% | 1,473,295 | 0.0% | 3.37% | -3.6% | |
| INCY | Incyte Corporation | $80,933,000 | -7.3% | 693,275 | 0.0% | 2.89% | -10.5% | |
| REGN | Sell | Regeneron Pharmaceuticals, Inc. | $76,241,000 | -17.3% | 170,516 | -9.1% | 2.73% | -20.2% |
| AGN | Buy | Allergan plcshares | $69,474,000 | -8.0% | 338,979 | +9.1% | 2.48% | -11.2% |
| ABT | Buy | Abbott Laboratories | $66,749,000 | +19.1% | 1,250,920 | +8.5% | 2.39% | +15.0% |
| ILMN | Buy | Illumina, Inc. | $63,085,000 | +30.3% | 316,691 | +13.5% | 2.26% | +25.8% |
| UNH | Sell | UnitedHealth Group Inc. | $54,021,000 | -5.2% | 275,826 | -10.3% | 1.93% | -8.6% |
| MYL | Mylan N.V.shares | $50,290,000 | -19.2% | 1,603,112 | 0.0% | 1.80% | -22.0% | |
| BMRN | BioMarin Pharmaceutical Inc. | $46,697,000 | +2.5% | 501,745 | 0.0% | 1.67% | -1.1% | |
| MDT | Medtronic plcshares | $45,132,000 | -12.4% | 580,326 | 0.0% | 1.61% | -15.5% | |
| TMO | Buy | Thermo Fisher Scientific Inc. | $41,448,000 | +70.8% | 219,072 | +57.5% | 1.48% | +64.8% |
| JAZZ | Jazz Pharmaceuticals plcshares | $40,060,000 | -5.9% | 273,916 | 0.0% | 1.43% | -9.3% | |
| SHPG | Shire plcsponsored adr | $38,609,000 | -7.3% | 252,113 | 0.0% | 1.38% | -10.6% | |
| NBIX | Neurocrine Biosciences, Inc. | $34,468,000 | +33.2% | 562,467 | 0.0% | 1.23% | +28.6% | |
| NVS | Novartis AGsponsored adr | $34,225,000 | +2.9% | 398,662 | 0.0% | 1.22% | -0.8% | |
| CVS | CVS Health Corporation | $33,495,000 | +1.1% | 411,891 | 0.0% | 1.20% | -2.5% | |
| LLY | Sell | Eli Lilly & Company | $33,198,000 | -18.2% | 388,100 | -21.3% | 1.19% | -21.0% |
| TEVA | Buy | Teva Pharmaceutical Industries Ltd.sponsored adr | $30,915,000 | -8.4% | 1,756,558 | +72.9% | 1.10% | -11.6% |
| HUM | Humana Inc. | $30,400,000 | +1.2% | 124,781 | 0.0% | 1.09% | -2.2% | |
| PFE | Pfizer Inc. | $28,920,000 | +6.3% | 810,087 | 0.0% | 1.03% | +2.6% | |
| SRPT | Buy | Sarepta Therapeutics, Inc. | $24,340,000 | +41.1% | 536,600 | +4.9% | 0.87% | +36.2% |
| ABC | Buy | AmerisourceBergen Corporation | $23,847,000 | -1.0% | 288,187 | +13.1% | 0.85% | -4.6% |
| CNC | Buy | Centene Corporation | $22,272,000 | +44.8% | 230,158 | +19.5% | 0.80% | +39.6% |
| MCK | McKesson Corporation | $21,936,000 | -6.6% | 142,800 | 0.0% | 0.78% | -9.9% | |
| IDXX | IDEXX Laboratories, Inc. | $20,579,000 | -3.7% | 132,352 | 0.0% | 0.74% | -7.0% | |
| XBI | SPDR S&P Biotech ETFs&p biotech etf | $19,605,000 | +12.2% | 226,460 | 0.0% | 0.70% | +8.3% | |
| CI | Buy | Cigna Corporation | $18,694,000 | +33.1% | 100,002 | +19.2% | 0.67% | +28.5% |
| NVRO | Nevro Corp. | $17,687,000 | +22.1% | 194,621 | 0.0% | 0.63% | +17.7% | |
| PIRS | Pieris Pharmaceuticals, Inc. | $16,344,000 | +13.8% | 2,837,573 | 0.0% | 0.58% | +9.8% | |
| AZN | Sell | AstraZeneca PLCsponsored adr | $14,995,000 | -20.1% | 442,600 | -19.6% | 0.54% | -22.9% |
| OHI | Omega Healthcare Investors, Inc. | $14,634,000 | -3.4% | 458,616 | 0.0% | 0.52% | -6.8% | |
| GSK | GlaxoSmithKline plcshares | $14,575,000 | -5.8% | 359,000 | 0.0% | 0.52% | -9.1% | |
| CRL | Charles River Laboratories International, Inc. | $13,729,000 | +6.8% | 127,100 | 0.0% | 0.49% | +3.2% | |
| ALNY | Alnylam Pharmaceuticals, Inc. | $13,507,000 | +47.3% | 114,966 | 0.0% | 0.48% | +42.1% | |
| MPW | Medical Properties Trust, Inc. | $13,231,000 | +2.0% | 1,007,717 | 0.0% | 0.47% | -1.5% | |
| ACHC | Buy | Acadia Healthcare Company, Inc. | $13,010,000 | +14.0% | 272,400 | +17.8% | 0.46% | +9.9% |
| WELLPRI | Welltower Inc.6.50% preferred perpetual | $12,686,000 | -4.3% | 200,000 | 0.0% | 0.45% | -7.5% | |
| PBYI | Sell | Puma Biotechnology, Inc. | $12,633,000 | -28.6% | 105,495 | -47.9% | 0.45% | -31.1% |
| SNH | Senior Housing Properties Trustshares | $12,640,000 | -4.4% | 646,554 | 0.0% | 0.45% | -7.8% | |
| SGEN | Seattle Genetics, Inc. | $12,172,000 | +5.2% | 223,700 | 0.0% | 0.44% | +1.4% | |
| SBRA | Sabra Health Care REIT, Inc. | $12,089,000 | -9.0% | 550,990 | 0.0% | 0.43% | -12.2% | |
| VTR | Ventas, Inc. | $11,462,000 | -6.3% | 175,991 | 0.0% | 0.41% | -9.5% | |
| DERM | Buy | Dermira, Inc. | $10,716,000 | -4.9% | 396,900 | +2.6% | 0.38% | -8.4% |
| EW | New | Edwards Lifesciences Corporation | $10,647,000 | – | 97,400 | +100.0% | 0.38% | – |
| Aegerion Pharmaceuticals, Inc.note 2.00% 5/15/19 | $10,303,000 | -2.3% | 13,000,000 | 0.0% | 0.37% | -5.9% | ||
| CTMX | CytomX Therapeutics, Inc. | $9,632,000 | +17.2% | 530,092 | 0.0% | 0.34% | +13.2% | |
| DPLO | Diplomat Pharmacy, Inc. | $9,562,000 | +39.9% | 461,712 | 0.0% | 0.34% | +35.2% | |
| MRUS | Merus B.V. | $9,521,000 | +25.4% | 479,150 | 0.0% | 0.34% | +21.0% | |
| EXEL | Sell | Exelixis, Inc. | $9,421,000 | -30.7% | 388,822 | -29.5% | 0.34% | -33.0% |
| DOC | Physicians Realty Trust | $9,409,000 | -12.0% | 530,672 | 0.0% | 0.34% | -15.2% | |
| ABBV | Buy | AbbVie Inc. | $9,287,000 | +61813.3% | 104,513 | +48967.1% | 0.33% | +33100.0% |
| NUVA | New | NuVasive, Inc. | $8,961,000 | – | 161,576 | +100.0% | 0.32% | – |
| SNY | Sanofisponsored adr | $8,957,000 | +3.9% | 179,900 | 0.0% | 0.32% | +0.3% | |
| CLLS | Cellectis S.A.sponsored adr | $8,827,000 | +10.2% | 310,250 | 0.0% | 0.32% | +6.4% | |
| EPZM | Buy | Epizyme, Inc. | $8,687,000 | +104.7% | 456,000 | +62.3% | 0.31% | +98.1% |
| ANTM | New | Anthem, Inc. | $8,529,000 | – | 44,918 | +100.0% | 0.30% | – |
| KPTI | Karyopharm Therapeutics Inc. | $8,308,000 | +21.3% | 756,679 | 0.0% | 0.30% | +16.9% | |
| ZBH | Sell | Zimmer Biomet Holdings, Inc. | $7,939,000 | -39.6% | 67,800 | -33.7% | 0.28% | -41.7% |
| RARE | Buy | Ultragenyx Pharmaceutical Inc. | $7,912,000 | +0.1% | 148,558 | +16.7% | 0.28% | -3.4% |
| ENDP | Endo International plcshares | $7,833,000 | -23.3% | 914,548 | 0.0% | 0.28% | -25.9% | |
| PRAH | PRA Health Sciences, Inc. | $7,769,000 | +1.5% | 102,000 | 0.0% | 0.28% | -1.8% | |
| ADAP | Sell | Adaptimmune Therapeutics plcsponsored adr | $7,661,000 | +16.4% | 935,368 | -36.2% | 0.27% | +12.3% |
| HCA | HCA Healthcare, Inc. | $7,580,000 | -8.7% | 95,232 | 0.0% | 0.27% | -12.0% | |
| TSRO | New | TESARO, Inc. | $7,436,000 | – | 57,595 | +100.0% | 0.27% | – |
| ICPT | New | Intercept Pharmaceuticals, Inc. | $7,151,000 | – | 123,200 | +100.0% | 0.26% | – |
| WMGI | Buy | Wright Medical Group N.V.ordinary shares | $6,902,000 | +16.9% | 266,781 | +24.2% | 0.25% | +12.8% |
| AVDL | Avadel Pharmaceuticals plcsponsored adr | $6,555,000 | -4.8% | 624,288 | 0.0% | 0.23% | -8.2% | |
| LTC | LTC Properties, Inc. | $6,399,000 | -8.6% | 136,212 | 0.0% | 0.23% | -11.6% | |
| ENTL | Entellus Medical, Inc. | $6,304,000 | +11.5% | 341,471 | 0.0% | 0.22% | +7.7% | |
| NTRA | Natera, Inc. | $6,261,000 | +18.7% | 485,758 | 0.0% | 0.22% | +14.9% | |
| CLVS | Sell | Clovis Oncology, Inc. | $6,213,000 | -56.0% | 75,400 | -50.0% | 0.22% | -57.6% |
| MYOV | Myovant Sciences Ltd. | $6,188,000 | +32.2% | 400,000 | 0.0% | 0.22% | +27.7% | |
| VRX | Sell | Valeant Pharmaceuticals International, Inc. | $6,090,000 | -18.1% | 425,000 | -1.2% | 0.22% | -21.0% |
| TTPH | Sell | Tetraphase Pharmaceuticals, Inc. | $5,878,000 | -17.9% | 859,322 | -14.4% | 0.21% | -20.8% |
| RARX | Ra Pharmaceuticals, Inc. | $5,779,000 | -22.1% | 395,818 | 0.0% | 0.21% | -24.7% | |
| UHS | Universal Health Services, Inc.class b | $5,334,000 | -9.1% | 48,076 | 0.0% | 0.19% | -12.0% | |
| New | Intercept Pharmaceuticals, Inc.note 3.250% 7/1/23 | $5,330,000 | – | 6,900,000 | +100.0% | 0.19% | – | |
| ESRX | Express Scripts Holding Company | $5,351,000 | -0.8% | 84,500 | 0.0% | 0.19% | -4.5% | |
| DXCM | Buy | DexCom, Inc. | $5,279,000 | -14.6% | 107,900 | +27.7% | 0.19% | -17.5% |
| SNR | New Senior Investment Group Inc. | $5,197,000 | -9.0% | 567,997 | 0.0% | 0.19% | -11.8% | |
| FOMX | Foamix Pharmaceuticals Ltd.shares | $5,164,000 | +19.6% | 930,398 | 0.0% | 0.18% | +15.6% | |
| HSIC | New | Henry Schein, Inc. | $5,149,000 | – | 62,800 | +100.0% | 0.18% | – |
| UTHR | United Therapeutics Corporation | $5,152,000 | -9.7% | 43,961 | 0.0% | 0.18% | -12.8% | |
| CAH | Cardinal Health, Inc. | $5,126,000 | -14.1% | 76,600 | 0.0% | 0.18% | -17.2% | |
| SYK | New | Stryker Corporation | $4,474,000 | – | 31,500 | +100.0% | 0.16% | – |
| VRNA | Verona Pharma plcsponsored adr | $4,221,000 | +31.5% | 275,000 | 0.0% | 0.15% | +26.9% | |
| FOLD | Buy | Amicus Therapeutics, Inc. | $4,154,000 | +156.6% | 275,494 | +71.4% | 0.15% | +146.7% |
| AGNPRA | Allergan plcpreferred convertible series a | $3,689,000 | -15.0% | 5,000 | 0.0% | 0.13% | -18.0% | |
| Egalet Corporationnote 5.50% 4/1/20 | $3,601,000 | -19.2% | 7,000,000 | 0.0% | 0.13% | -21.8% | ||
| ARDX | Ardelyx, Inc. | $3,580,000 | +9.8% | 639,370 | 0.0% | 0.13% | +5.8% | |
| NVO | Sell | Novo Nordisk A/Ssponsored adr | $3,544,000 | -62.0% | 73,600 | -66.1% | 0.13% | -63.2% |
| INVA | Innoviva, Inc. | $3,513,000 | +10.3% | 248,803 | 0.0% | 0.13% | +6.8% | |
| AXDX | Buy | Accelerate Diagnostics, Inc. | $3,368,000 | +23.1% | 150,000 | +50.0% | 0.12% | +18.8% |
| AMRN | New | Amarin Corporation plcsponsored adr | $3,347,000 | – | 956,300 | +100.0% | 0.12% | – |
| AFMD | Affimed N.V. | $3,162,000 | +9.8% | 1,405,324 | 0.0% | 0.11% | +5.6% | |
| PRGO | Perrigo Company plcshares | $3,157,000 | +12.1% | 37,300 | 0.0% | 0.11% | +8.7% | |
| MNTA | Momenta Pharmaceuticals, Inc. | $2,829,000 | +9.5% | 152,900 | 0.0% | 0.10% | +5.2% | |
| GNMK | Buy | GenMark Diagnostics, Inc. | $2,838,000 | +157.1% | 294,749 | +215.7% | 0.10% | +146.3% |
| ACHN | New | Achillion Pharmaceuticals, Inc. | $2,766,000 | – | 616,000 | +100.0% | 0.10% | – |
| THC | Sell | Tenet Healthcare Corporation | $2,703,000 | -55.4% | 164,500 | -47.5% | 0.10% | -56.9% |
| Trillium Therapeutics Inc. | $2,575,000 | +30.1% | 500,000 | 0.0% | 0.09% | +26.0% | ||
| JUNO | Juno Therapeutics, Inc. | $2,553,000 | +50.1% | 56,900 | 0.0% | 0.09% | +44.4% | |
| IPXL | Impax Laboratories, Inc. | $2,524,000 | +26.1% | 124,335 | 0.0% | 0.09% | +21.6% | |
| SNDX | Syndax Pharmaceuticals, Inc. | $2,340,000 | -16.2% | 200,000 | 0.0% | 0.08% | -19.2% | |
| QURE | uniQure N.V.shares | $2,314,000 | +55.1% | 241,021 | 0.0% | 0.08% | +50.9% | |
| CDTX | Cidara Therapeutics, Inc. | $2,320,000 | +8.0% | 286,472 | 0.0% | 0.08% | +3.8% | |
| MNKKQ | Mallinckrodt plcshares | $2,313,000 | -16.6% | 61,900 | 0.0% | 0.08% | -19.4% | |
| XLRN | Acceleron Pharma Inc. | $2,226,000 | +22.8% | 59,654 | 0.0% | 0.08% | +19.4% | |
| HR | Healthcare Realty Trust Incorporated | $2,199,000 | -5.3% | 68,000 | 0.0% | 0.08% | -8.1% | |
| EVH | New | Evolent Health, Inc.class a | $2,181,000 | – | 122,500 | +100.0% | 0.08% | – |
| ONCE | Spark Therapeutics, Inc. | $2,167,000 | +49.2% | 24,300 | 0.0% | 0.08% | +42.6% | |
| GKOS | New | Glaukos Corporation | $2,102,000 | – | 63,707 | +100.0% | 0.08% | – |
| HZNP | Horizon Pharma plcshares | $2,066,000 | +6.8% | 162,900 | 0.0% | 0.07% | +2.8% | |
| GBT | Sell | Global Blood Therapeutics, Inc. | $1,941,000 | -43.2% | 62,500 | -50.0% | 0.07% | -45.7% |
| GLPG | Galapagos NVsponsored adr | $1,933,000 | +32.9% | 19,000 | 0.0% | 0.07% | +27.8% | |
| NSTG | NanoString Technologies, Inc. | $1,834,000 | -2.3% | 113,500 | 0.0% | 0.07% | -5.7% | |
| CASC | New | Cascadian Therapeutics, Inc. | $1,856,000 | – | 453,900 | +100.0% | 0.07% | – |
| BLUE | bluebird bio, Inc. | $1,823,000 | +30.8% | 13,273 | 0.0% | 0.06% | +25.0% | |
| BCRX | New | BioCryst Pharmaceuticals, Inc. | $1,694,000 | – | 323,255 | +100.0% | 0.06% | – |
| CBAY | New | CymaBay Therapeutics, Inc. | $1,692,000 | – | 209,962 | +100.0% | 0.06% | – |
| ARGX | argenx SEsponsored adr | $1,683,000 | +5.8% | 75,000 | 0.0% | 0.06% | +1.7% | |
| CYH | Community Health Systems, Inc. | $1,566,000 | -22.9% | 203,935 | 0.0% | 0.06% | -25.3% | |
| WELL | Welltower Inc. | $1,504,000 | -6.1% | 21,400 | 0.0% | 0.05% | -8.5% | |
| OVID | Sell | Ovid Therapeutics Inc. | $1,393,000 | -73.4% | 162,537 | -69.7% | 0.05% | -74.2% |
| HTA | Healthcare Trust of America, Inc.class a | $1,371,000 | -4.2% | 46,000 | 0.0% | 0.05% | -7.5% | |
| HCP | HCP, Inc. | $1,266,000 | -12.9% | 45,500 | 0.0% | 0.04% | -16.7% | |
| CHRS | Coherus BioSciences, Inc. | $1,202,000 | -7.0% | 90,000 | 0.0% | 0.04% | -10.4% | |
| ADVM | New | Adverum Biotechnologies, Inc. | $1,095,000 | – | 300,078 | +100.0% | 0.04% | – |
| XENE | Xenon Pharmaceuticals Inc. | $1,033,000 | -6.3% | 350,000 | 0.0% | 0.04% | -9.8% | |
| AVXS | AveXis, Inc. | $967,000 | +17.6% | 10,000 | 0.0% | 0.04% | +16.7% | |
| ABIO | ARCA biopharma, Inc. | $892,000 | -55.1% | 811,227 | 0.0% | 0.03% | -56.8% | |
| BLCM | Bellicum Pharmaceuticals, Inc. | $693,000 | -1.1% | 60,000 | 0.0% | 0.02% | -3.8% | |
| GMRE | Global Medical REIT Inc. | $659,000 | +0.5% | 73,400 | 0.0% | 0.02% | 0.0% | |
| EARS | Auris Medical Holding AG | $635,000 | +14.6% | 774,504 | 0.0% | 0.02% | +9.5% | |
| NVAX | Novavax, Inc. | $651,000 | -0.9% | 571,000 | 0.0% | 0.02% | -4.2% | |
| ALQA | Alliqua BioMedical, Inc. | $602,000 | -1.5% | 1,650,000 | 0.0% | 0.02% | -4.3% | |
| QTNT | New | Quotient Limited | $586,000 | – | 118,861 | +100.0% | 0.02% | – |
| ACIU | New | AC Immune SAshares | $462,000 | – | 40,919 | +100.0% | 0.02% | – |
| XNCR | Xencor, Inc. | $458,000 | +8.5% | 20,000 | 0.0% | 0.02% | 0.0% | |
| RMR | The RMR Group Inc.class a | $382,000 | +5.5% | 7,441 | 0.0% | 0.01% | +7.7% | |
| EIGR | New | Eiger BioPharmaceuticals, Inc. | $341,000 | – | 31,028 | +100.0% | 0.01% | – |
| CLDX | Celldex Therapeutics, Inc. | $303,000 | +16.1% | 105,800 | 0.0% | 0.01% | +10.0% | |
| PTGX | New | Protagonist Therapeutics, Inc. | $138,000 | – | 7,822 | +100.0% | 0.01% | – |
| QHCCQ | Quorum Health Corporationshares | $123,000 | +25.5% | 23,725 | 0.0% | 0.00% | 0.0% | |
| ZFGN | Zafgen, Inc. | $47,000 | 0.0% | 13,307 | 0.0% | 0.00% | 0.0% | |
| NTLA | Exit | Intellia Therapeutics, Inc. | $0 | – | -28,000 | -100.0% | -0.02% | – |
| MDRX | Exit | Allscripts Healthcare Solutions, Inc. | $0 | – | -47,300 | -100.0% | -0.02% | – |
| FLKS | Exit | Flex Pharma, Inc. | $0 | – | -159,549 | -100.0% | -0.02% | – |
| Exit | Nabriva Therapeutics plcshares | $0 | – | -149,334 | -100.0% | -0.06% | – | |
| DBVT | Exit | DBV Technologies S.A.sponsored adr | $0 | – | -63,800 | -100.0% | -0.08% | – |
| RTRX | Exit | Retrophin, Inc. | $0 | – | -167,949 | -100.0% | -0.12% | – |
| DVAX | Exit | Dynavax Technologies Corporation | $0 | – | -345,050 | -100.0% | -0.12% | – |
| SAGE | Exit | Sage Therapeutics, Inc. | $0 | – | -90,480 | -100.0% | -0.27% | – |
| BMY | Exit | Bristol-Myers Squibb Co. | $0 | – | -186,500 | -100.0% | -0.38% | – |
| AKRXQ | Exit | Akorn, Inc. | $0 | – | -327,735 | -100.0% | -0.41% | – |
| PRTK | Exit | Paratek Pharmaceuticals, Inc. | $0 | – | -533,000 | -100.0% | -0.48% | – |
| IBB | Exit | iShares Nasdaq Biotechnology ETFnasdaq biotech etf | $0 | – | -75,970 | -100.0% | -0.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.